L. Varga

发表

The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.

P. Gál, H. Farkas, G. Füst, 2013, Molecular immunology.

Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency

J. Skopál, H. Farkas, Z. Prohászka, 2015, Orphanet Journal of Rare Diseases.

Effectiveness of a Hungarian peer education handwashing programme in primary and secondary schools

Á. Lukács, Z. Molnár, L. Varga, 2020, Developments in Health Sciences.

Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.

H. Farkas, G. Füst, P. Gergely, 2011, Clinical Immunology.

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

P. Keith, J. Bernstein, R. Schellenberg, 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Acquired angioedema associated with chronic hepatitis C.

H. Farkas, G. Füst, A. Pár, 1999, The Journal of allergy and clinical immunology.

High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer

T. Mészáros, Z. Prohászka, G. Füst, 2010, Cell Stress and Chaperones.

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

A. Tordai, L. Truedsson, M. López-Trascasa, 2004, Journal of Allergy and Clinical Immunology.

[Effect of danazol treatment on growth in pediatric patients with hereditary angioedema due to C1-inhibitor deficiency].

H. Farkas, L. Varga, N. Veszeli, 2017, Orvosi hetilap.

The effect of long-term danazol treatment on haematological parameters in hereditary angioedema

H. Farkas, D. Csuka, É. Imreh, 2016, Orphanet Journal of Rare Diseases.

Pathways of Neutrophil Granulocyte Activation in Hereditary Angioedema with C1 Inhibitor Deficiency

H. Farkas, L. Cervenak, E. Kajdácsi, 2021, Clinical Reviews in Allergy & Immunology.

Hereditary Angioedema: A Family with Several Affected Members

H. Farkas, Z. Chavoshzadeh, S. Darougar, 2019 .

Role of Complement in Allergy

H. Farkas, G. Füst, L. Varga, 2004 .

A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission.

Z. Nagy, Z. Illés, Z. Prohászka, 2014, Molecular immunology.

Danazol therapy for hereditary angio-oedema in children

H. Farkas, L. Varga, G. Harmat, 1999, The Lancet.

Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.

William H. Yang, P. Keith, R. Schellenberg, 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

William H. Yang, H. Farkas, R. Warrington, 2004, The Journal of allergy and clinical immunology.

Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations.

C. Y. Yu, G. Füst, C. Szalai, 2003, Human immunology.

Endothelial cell activation during edematous attacks of hereditary angioedema types I and II.

H. Farkas, Z. Prohászka, L. Cervenak, 2014, The Journal of allergy and clinical immunology.

Anti-cholesterol antibody levels in hereditary angioedema

H. Farkas, G. Füst, G. Szeplaki, 2007, Journal of cellular and molecular medicine.

Prophylactic therapy in children with hereditary angioedema.

H. Farkas, G. Füst, D. Csuka, 2013, The Journal of allergy and clinical immunology.

Abstracts of 11th C1-inhibitor Deficiency & Angioedema Workshop

A. Maetzel, H. Farkas, E. Feener, 2019, Allergy, Asthma & Clinical Immunology.

Assays for Complement Proteins Encoded in the Class III Region of Human MHC

G. Füst, L. Varga, 2005, Current protocols in immunology.

This information is current as Activities , and Body Mass Index and Polygenic Variations , Hemolytic Gene Size C 4 Concentrations Correlate with Complement System : Serum C 4 Protein Diversity in Intrinsic Strengths of the Human

C. Y. Yu, C. Szalai, M. Kovács, 2003 .

The importance of complement testing in acquired angioedema related to angiotensin-converting enzyme inhibitors.

H. Farkas, D. Csuka, L. Varga, 2020, The journal of allergy and clinical immunology. In practice.

Atrial natriuretic peptide as a novel biomarker of hereditary angioedema.

H. Farkas, Z. Prohászka, L. Cervenak, 2016, Clinical immunology.

Coincidence of hereditary angioedema (HAE) with Crohn's disease.

H. Farkas, G. Füst, M. Bély, 1999, Immunological investigations.

[Analysis of the relationship between vitamin D3 level and disease severity in hereditary angioedema].

H. Farkas, É. Imreh, L. Varga, 2019, Orvosi hetilap.

Screening for Plasminogen Mutations in Hereditary Angioedema Patients

H. Farkas, D. Csuka, L. Varga, 2021, Genes.

Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations.

A. Tordai, Á. Szilágyi, H. Farkas, 2013, The Journal of allergy and clinical immunology.

Relationship between copy number of genes (C4A, C4B) encoding the fourth component of complement and the clinical course of hereditary angioedema (HAE).

Z. Rónai, H. Farkas, Z. Prohászka, 2007, Molecular Immunology.

Treatment with C1-inhibitor concentrate does not induce IgM type anti-C1 inhibitor antibodies in patients with hereditary angioedema.

H. Farkas, G. Füst, D. Csuka, 2011, Molecular immunology.

XXIV World Allergy Congress 2015

Dong Hun Lee, Young Han Kim, Byung Soo Kim, 2016, The World Allergy Organization Journal.

Association of celiac disease and hereditary angioneurotic edema

A. Tordai, L. Kalmár, H. Farkas, 2002, American Journal of Gastroenterology.

Coexistent systemic mastocytosis and essential thrombocythemia complicated with monoclonal gammopathy and hypocomplementaemia

H. Farkas, J. Csomor, I. Karádi, 2012 .

The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update

R. Lockey, R. Pawankar, W. Aberer, 2022, The World Allergy Organization journal.

Management of Hereditary Angioedema in Pediatric Patients

H. Farkas, G. Szeplaki, L. Varga, 2007, Pediatrics.

Clinical management of hereditary angio‐oedema in children

H. Farkas, G. Füst, L. Varga, 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema

H. Farkas, G. Füst, I. Karádi, 2001, The Lancet.

The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures.

H. Farkas, G. Füst, L. Varga, 1999, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Assessment of inhibitory antibodies in patients with hereditary angioedema treated with plasma-derived C1 inhibitor.

T. Machnig, H. Farkas, J. Edelman, 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

“Nuts and Bolts” of Laboratory Evaluation of Angioedema

H. Farkas, L. Cervenak, E. Kajdácsi, 2016, Clinical Reviews in Allergy & Immunology.

Acquired Angioedema Associated with Primary Antiphospholipid Syndrome in a Patient with Antithrombin III Deficiency

H. Farkas, G. Füst, G. Szeplaki, 2008, International Archives of Allergy and Immunology.

C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.

H. Farkas, G. Füst, L. Cervenak, 2007, Molecular immunology.

Angioedema due to acquired C1-esterase inhibitor deficiency in a patient with Helicobacter pylori infection.

H. Farkas, G. Füst, L. Varga, 1999, Zeitschrift fur Gastroenterologie.

C1r-C1s-C1inhibitor (C1rs-C1inh) complex measurements in tears of patients before and after penetrating keratoplasty

G. Füst, G. Nagy, I. Süveges, 2002, Current eye research.

Esophageal leiomyoma incidentally recognized during an acute attack of hereditary angioneurotic edema.

H. Farkas, G. Füst, L. Varga, 2001, The Journal of allergy and clinical immunology.

Dancing with complement C4 and the RP-C4-CYP21-TNX (RCCX) modules of the major histocompatibility complex.

W. Miller, C. Y. Yu, K. Saxena, 2003, Progress in nucleic acid research and molecular biology.

The role of complement activation in the pathogenesis of Fuchs' dystrophy.

G. Füst, J. Németh, D. Csuka, 2014, Molecular immunology.

The role of the complement system in hereditary angioedema.

H. Farkas, Z. Prohászka, D. Csuka, 2017, Molecular immunology.

Overview of SERPING1 Variations Identified in Hungarian Patients With Hereditary Angioedema

Á. Szilágyi, H. Farkas, D. Csuka, 2022, Frontiers in Allergy.

Hereditary angioedema: molecular and clinical differences among European populations.

A. Tordai, Á. Szilágyi, H. Farkas, 2015, The Journal of allergy and clinical immunology.

Diversity in Intrinsic Strengths of the Human Complement System: Serum C4 Protein Concentrations Correlate with C4 Gene Size and Polygenic Variations, Hemolytic Activities, and Body Mass Index 1

C. Y. Yu, C. Szalai, M. Kovács, 2003, The Journal of Immunology.

Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.

H. Farkas, G. Füst, L. Jakab, 2007, The Journal of allergy and clinical immunology.

Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes.

L. Entz, Z. Prohászka, G. Füst, 2009, Atherosclerosis.

International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency

M. Triggiani, P. Schmid‐Grendelmeier, W. Aberer, 2016, Allergy.

Diagnosing Pediatric Patients With Hereditary C1-Inhibitor Deficiency—Experience From the Hungarian Angioedema Center of Reference and Excellence

Á. Szilágyi, H. Farkas, D. Csuka, 2022, Frontiers in Allergy.

Clinical characteristics and safety of plasma-derived C1-inhibitor therapy in children and adolescents with hereditary angioedema - a long-term survey.

H. Farkas, L. Varga, N. Veszeli, 2020, The journal of allergy and clinical immunology. In practice.

Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor.

H. Farkas, Z. Zotter, L. Varga, 2016, Allergy and asthma proceedings.

Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood

H. Farkas, F. Tóth, L. Kőszegi, 2015, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patients.

H. Farkas, G. Füst, D. Csuka, 2013, The Journal of allergy and clinical immunology.

C1 inhibitors for hereditary angioedema

H. Farkas, L. Varga, 2012 .

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency

H. Farkas, L. Varga, 2011, Clinical, cosmetic and investigational dermatology.

rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency

H. Farkas, L. Varga, 2011, Expert review of clinical immunology.

The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study

H. Farkas, Z. Prohászka, G. Füst, 2010, European Journal of Clinical Pharmacology.

Treatment of type I and II hereditary angioedema with Rhucin®, a recombinant human C1 inhibitor

H. Farkas, L. Varga, 2008, Expert review of clinical immunology.

Sex hormones in hereditary angioneurotic oedema

H. Farkas, G. Füst, E. Takács, 2004, Clinical endocrinology.

The Hungarian HAE experience.

H. Farkas, L. Varga, 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema

H. Farkas, G. Füst, P. Kaposi, 2001, European journal of gastroenterology & hepatology.

Recombinant human C1‐inhibitor in the treatment of acute angioedema attacks

H. Farkas, M. Soeters, J. Nuijens, 2007, Transfusion.

Successful prophylaxis with recombinant human C1 inhibitor in a patient with hereditary angioedema.

H. Farkas, Z. Zotter, L. Varga, 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients

C. Maas, P. Gál, H. Farkas, 2020, Frontiers in Immunology.

Complete kinetic follow‐up of symptoms and complement parameters during a hereditary angioedema attack

H. Farkas, L. Cervenak, E. Kajdácsi, 2018, Allergy.

Long‐term efficacy of danazol treatment in hereditary angioedema

H. Farkas, G. Füst, K. Bork, 2011, European journal of clinical investigation.

Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema.

L. Romics, H. Farkas, G. Füst, 2005, The Journal of allergy and clinical immunology.

Short‐term prophylaxis in hereditary angioedema due to deficiency of the C1‐inhibitor – a long‐term survey

H. Farkas, L. Jakab, I. Karádi, 2012, Allergy.

Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency.

H. Farkas, D. Csuka, Z. Zotter, 2014, Allergy and asthma proceedings.

The Global Registry for Hereditary Angioedema due to C1-Inhibitor Deficiency

H. Farkas, L. Bouillet, A. Germenis, 2021, Clinical Reviews in Allergy & Immunology.

Functional C1-inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations.

H. Joller-jemelka, L. Truedsson, C. Hack, 2008, Journal of immunological methods.

Evaluation of the efficacy and safety of home treatment with the recombinant human C1-inhibitor in hereditary angioedema resulting from C1-inhibitor deficiency.

H. Farkas, L. Varga, N. Veszeli, 2020, International immunopharmacology.

Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency

H. Farkas, L. Varga, 2012, Biologics in therapy.

Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema

H. Farkas, D. Csuka, Z. Zotter, 2014, Orphanet Journal of Rare Diseases.

Parameters of the classical complement pathway predict disease severity in hereditary angioedema.

H. Farkas, G. Füst, D. Csuka, 2011, Clinical immunology.

Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema.

H. Farkas, G. Füst, G. Szeplaki, 2010, Clinical immunology.

Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.

H. Farkas, D. Csuka, É. Imreh, 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Idiopathic Nonhistaminergic Acquired Angioedema Versus Hereditary Angioedema.

H. Farkas, D. Csuka, L. Varga, 2018, The journal of allergy and clinical immunology. In practice.

Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema

A. Tordai, L. Kalmár, H. Farkas, 2003, Human mutation.

Successful outcome using C1-inhibitor concentrate in acute pancreatitis caused by hereditary angioedema.

H. Farkas, D. Csuka, L. Varga, 2011, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

First report of icatibant treatment in a pregnant patient with hereditary angioedema

H. Farkas, F. Tóth, L. Varga, 2016, The journal of obstetrics and gynaecology research.

Successful pregnancy outcome after treatment with C1-inhibitor concentrate in a patient with hereditary angioedema and a history of four miscarriages.

H. Farkas, F. Tóth, L. Kőszegi, 2012, European journal of obstetrics, gynecology, and reproductive biology.

Abstracts from the 10th C1-inhibitor deficiency workshop

William H. Yang, A. Szilágyi, M. Margaglione, 2017, Allergy, Asthma & Clinical Immunology.

The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency

H. Farkas, D. Csuka, G. Fust, 2014, Orphanet Journal of Rare Diseases.

Angiooedema due to acquired deficiency of C1-esterase inhibitor associated with leucocytoclastic vasculitis.

H. Farkas, G. Füst, M. Bély, 2001, Acta dermato-venereologica.

F12‐46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema

Á. Szilágyi, H. Farkas, M. Magerl, 2015, Allergy.

A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin‐forming enzymes

H. Farkas, A. Kaplan, C. Koch, 2015, Allergy.

Novel duplication in the F12 gene in a patient with recurrent angioedema.

Á. Szilágyi, H. Farkas, Z. Prohászka, 2013, Clinical immunology.

Erythema marginatum preceding an acute oedematous attack of hereditary angioneurotic oedema.

H. Farkas, I. Karádi, L. Varga, 2001, Acta dermato-venereologica.

Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency

H. Farkas, L. Varga, S. Benedek, 2022, Heliyon.

How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?

H. Farkas, L. Varga, K. V. Kőhalmi, 2021, Clinical Reviews in Allergy & Immunology.

A follow‐up survey of patients with acquired angioedema due to C1‐inhibitor deficiency

H. Farkas, L. Varga, S. Benedek, 2020, Journal of internal medicine.

C1 inhibitor: quantification and purification.

J. Dobó, L. Varga, 2014, Methods in molecular biology.

The Levels of the Lectin Pathway Serine Protease MASP-1 and Its Complex Formation with C1 Inhibitor Are Linked to the Severity of Hereditary Angioedema

K. Skjødt, H. Farkas, P. Garred, 2015, The Journal of Immunology.

C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency

H. Farkas, L. Cervenak, E. Kajdácsi, 2023, Orphanet Journal of Rare Diseases.

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency

H. Farkas, M. Józsi, D. Csuka, 2015, Orphanet Journal of Rare Diseases.

Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients.

H. Farkas, Z. Prohászka, G. Füst, 2008, Atherosclerosis.

Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1

H. Farkas, Z. Prohászka, L. Cervenak, 2016, Journal of Clinical Immunology.

Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema.

H. Farkas, M. Jesenak, L. Varga, 2020, International immunopharmacology.

Acute abdominal attack of hereditary angioneurotic oedema associated with ultrasound abnormalities suggestive of acute hepatitis

H. Farkas, I. Karádi, L. Varga, 2002, Acta paediatrica.

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency

H. Farkas, D. Csuka, L. Varga, 2021, Clinical and translational allergy.

This information is current as the Severity of Hereditary Angioedema Formation with C 1 Inhibitor Are Linked to Protease MASP-1 and Its Complex The Levels of the Lectin Pathway Serine

K. Skjødt, H. Farkas, P. Garred, 2015 .

Definition, aims, and implementation of GA2LEN/HAEi Angioedema Centers of Reference and Excellence

Todor A Popov, T. Zuberbier, N. Papadopoulos, 2020, Allergy.

Strong correlation of high EBNA-1-IgG levels with edematous attacks involving upper airway mucosa in hereditary angioedema due to C1-inhibitor deficiency.

H. Farkas, G. Füst, D. Csuka, 2012, Molecular immunology.

Safety Of Plasma-derived C1-inhibitor Treatment In Pediatric Patients With Hereditary Angioedema Due To C1-inhibitor Deficiency – A Long-term Survey

H. Farkas, L. Varga, N. Veszeli, 2017 .

Home treatment of hereditary angioedema with icatibant administered by health care professionals.

H. Farkas, L. Jakab, D. Csuka, 2012, The Journal of allergy and clinical immunology.

A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.

H. Farkas, L. Cervenak, L. Varga, 2017, Immunology letters.

Association of celiac disease and hereditary angioneurotic edema.

A. Tordai, L. Kalmár, H. Farkas, 2002 .

Association of celiac disease and hereditary angioedema due to C1-inhibitor deficiency. Screening patients with hereditary angioedema for celiac disease: is it worth the effort?

H. Farkas, G. Füst, Z. Szabó, 2011, European journal of gastroenterology & hepatology.

[Efficacy of short-term danazol treatment in hereditary angioneurotic edema patients undergoing maxillofacial and dental surgical procedures].

H. Farkas, G. Füst, L. Varga, 1998, Fogorvosi szemle.

Activation of the ficolin-lectin pathway during attacks of hereditary angioedema.

H. Farkas, Z. Prohászka, P. Garred, 2014, The Journal of allergy and clinical immunology.

Activation of the ficolin-lectin pathway during attacks of hereditary angioedema

H. Farkas, Z. Prohászka, P. Garred, 2013 .

Bacteriuria increases the risk of edematous attacks in hereditary angioedema with C1‐inhibitor deficiency

H. Farkas, É. Imreh, Z. Zotter, 2016, Allergy.

Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women.

L. Romics, Z. Prohászka, G. Füst, 2004, Atherosclerosis.

Alternative complement pathway activation during invasive coronary procedures in acute myocardial infarction and stable angina pectoris.

I. Préda, R. Kiss, Z. Prohászka, 2016, Clinica chimica acta; international journal of clinical chemistry.

High Normal Serum Levels of C3 and C1 Inhibitor, Two Acute-Phase Proteins Belonging to the Complement System, Occur More Frequently in Patients with Crohn's Disease Than Ulcerative Colitis

M. Daha, H. Farkas, Z. Prohászka, 2003, Digestive Diseases and Sciences.

Studies on the interactions between C‐reactive protein and complement proteins

N. Thielens, G. Arlaud, D. Papp, 2007, Immunology.

Elevated C1rC1sC1inh levels independently predict atherosclerotic coronary heart disease.

I. Préda, R. Kiss, G. Füst, 2013, Molecular immunology.

Low C1-Inhibitor Levels Predict Early Restenosis After Eversion Carotid Endarterectomy

L. Entz, P. Gál, E. Dósa, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Elevated complement C3 is associated with early restenosis after eversion carotid endarterectomy

L. Entz, Z. Prohászka, G. Füst, 2006, Thrombosis and Haemostasis.

The Role of Mannose-binding Lectin in Infectious Complications of Pediatric Hemato-Oncologic Diseases.

Á. Szilágyi, Z. Prohászka, G. Kovács, 2020, The Pediatric infectious disease journal.

A novel assay to quantitate MASP-2/ficolin-3 complexes in serum.

G. Füst, P. Garred, M. Skjoedt, 2013, Journal of immunological methods.

Association of Low Ficolin–Lectin Pathway Parameters with Cardiac Syndrome X

I. Préda, Z. Prohászka, P. Garred, 2016, Scandinavian journal of immunology.

Role of complement in the pathomechanism of atherosclerotic vascular diseases.

Z. Prohászka, G. Füst, L. Varga, 2009, Molecular immunology.

Studies on the mechanisms of allergen-induced activation of the classical and lectin pathways of complement.

S. Thiel, M. Daha, N. Thielens, 2003, Molecular immunology.

Early complement activation follows eversion carotid endarterectomy and correlates with the time of clamping of the carotid artery.

L. Entz, E. Dósa, Z. Prohászka, 2008, Molecular immunology.

Depressed activation of the lectin pathway of complement in hereditary angioedema

P. Gál, H. Farkas, G. Füst, 2008, Clinical and experimental immunology.

Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis

H. Farkas, V. Nădăşan, L. Varga, 2021, Romanian Journal of Laboratory Medicine.

Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1

H. Farkas, Z. Prohászka, L. Cervenak, 2016, Journal of Clinical Immunology.

The use of ‘real‐time’ complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathies

Z. Prohászka, G. Füst, L. Varga, 2012, British journal of haematology.

ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY REVIEW Open Access

P. Keith, J. Bernstein, R. Schellenberg, 2022 .

High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients.

L. Czirják, M. Daha, L. Romics, 2001, Clinical and experimental rheumatology.

Usefulness of detection of complement activation products in evaluating SLE activity

G. Nagy, G. Füst, M. Brózik, 2000, Lupus.

Functional analysis of the mannose-binding lectin complement pathway in normal pregnancy and preeclampsia.

Z. Prohászka, G. Füst, D. Csuka, 2010, Journal of reproductive immunology.

Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group

M. Triggiani, W. Aberer, R. Perricone, 2012, Allergy.

Deep venous thrombosis associated with acquired angioedema type II in a patient heterozygous for the mutation of factor V Leiden: Effective treatment and follow-up for four years

H. Farkas, G. Füst, I. Karádi, 2006, Thrombosis and Haemostasis.

Short‐term prophylaxis in hereditary angioedema due to deficiency of the C1‐inhibitor – a long‐term survey

H. Farkas, D. Csuka, I. Karádi, 2012, Allergy.

Changes in the psychsocial status after cardiac surgery in a 10-years follow-up study

A. Székely, L. Varga, Enikő Holndonner-Kirst, 2015 .

Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes.

L. Entz, Z. Prohászka, G. Füst, 2009, Atherosclerosis.

Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor.

H. Farkas, Z. Zotter, L. Varga, 2016, Allergy and asthma proceedings.

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

A. Hamed, M. Cicardi, K. Binkley, 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

C. Szalai, I. Karádi, Erwin K. Chung, 2003 .